Pancreastatin inhibitor activates AMPK pathway via GRP78 and ameliorates dexamethasone-induced fatty liver disease in C57BL/6 mice
Fingerprint
Dive into the research topics of 'Pancreastatin inhibitor activates AMPK pathway via GRP78 and ameliorates dexamethasone-induced fatty liver disease in C57BL/6 mice'. Together they form a unique fingerprint.